Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.7 USD | +2.39% | +1.68% | +20.83% |
15/05 | Merck to present new oncology data | CF |
14/05 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.83% | 33TCr | |
+31.37% | 59TCr | |
-2.60% | 36TCr | |
+5.69% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+10.77% | 17TCr | |
+0.10% | 16TCr | |
+0.89% | 12TCr |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- BofA Securities Raises Merck Price Target to $135 From $130, Maintains Buy Rating